Specifying the Anti-inflammatory Effects of Ziltivekimab
Clinical trial NCT06263244 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06263244
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-03
- Primary completion
- 2026-09-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.